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Abstract
Background: Sleepwalking (SW) is found to affect children 
predominantly, but it can persist or appear de novo even 
among adults. In this study, we assessed the demographic, 
clinical and polysomnographic profile, trigger factors and as-
sociated comorbidities of adult-onset (AO-SW) and child-
hood-onset (CO-SW) adult sleepwalkers. Methods: In adult 
sleepwalkers, a structured clinical interview, a battery of 
questionnaires, video-polysomnography (v-PSG) and stan-
dard electroencephalography (EEG) were performed. Re-
sults: Among 63 sleepwalkers, 45% had ≥1 episodes/month, 
54% had partial recall of the episodes and 36% reported trig-
ger factors for SW. Almost all subjects reported co-occurring 
parasomnias. In v-PSG, 4% exhibited episodes of SW, 17% 
confusional arousals, 21% had an increased apnea-hypop-
nea-index and 6% exhibited features of an overlap parasom-
nia disorder. In our cohort, 73% reported CO-SW and 27% 
AO-SW. In subjects with AO-SW, positive family history for 
parasomnias was found in 33% (vs. 49% in CO-SW), neuro-
logical comorbidities in 44% (vs. 14%), psychiatric comorbid-
ities in 25% (vs. 33%), EEG abnormalities in 50% (vs. 29%). 
Violence during SW episodes was more frequent in males 
and in subjects with CO-SW (45% for self-injury and 44% for 
violent behaviour vs. 33 and 29% respectively in the AO-SW 
group). Conclusions: Adult SW represents a complex and 
potentially dangerous condition. The characteristics of AO-
SW often differ from those of CO-SW.
© 2017 S. Karger AG, Basel
Introduction
Sleepwalking (SW) is considered to be a disorder of 
impaired arousal [1]. This sleep disorder is a non-rapid 
eye movement sleep parasomnia, which occurs predomi-
nantly out of slow wave sleep and is characterized by a 
state of dissociated consciousness, in which phenomena 
of the sleeping and waking states coexist [1, 2]. SW is 
commonly found in the general population and the life-
time prevalence is about 29%. It typically affects children 
reaching a peak at around 10–13 years [3], disappearing 
in about 75% of the affected during the adolescence [4, 5]. 
SW can also persist or appear de novo in adulthood. 
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Among adult sleepwalkers, approximately 13% develop 
this sleep disturbance during adulthood [5]. The overall 
prevalence of SW in adulthood is about 4% [6].
Only a few studies in the past have assessed character-
istics and comorbidities of SW. In the study by Lopez et 
al. [7], SW was associated with an altered quality of life 
and several symptoms including daytime sleepiness, fa-
tigue, insomnia, depression and anxiety. In contrast, La-
belle et al. [8] reported that there was no association be-
tween adult SW and clinically significant levels of depres-
sion or anxiety and even if present, these symptoms had 
little impact on the phenomenological features of SW. 
Commonly reported trigger factors for SW include sleep 
deprivation and stress [9]. In addition, subjects with a 
longer history of SW reported more frequent episodes of 
SW [9]. Lam et al. [10] showed a higher prevalence of AO-
SW in a psychiatric outpatient cohort compared to the 
general population.
Data regarding differences between childhood-SW 
(CO-SW) and adult-onset SW (AO-SW) is limited. Lopez 
et al. [7] reported that subjects with late-onset (subjects 
older than 9 years) primary SW (subjects with comor-
bidities were excluded) had lower incidence of violent be-
haviours and were more prone to worsening of their SW 
over time compared to those with early-onset SW [7]. 
However, in another cohort, Bušková et al. [9] found no 
association between age at onset of SW with violent and 
injurious behaviour.
Most of the above-mentioned studies focused only on 
specific aspects of SW profiles (e.g., psychiatric comor-
bidities), reported results independent of the age at onset 
of SW (childhood- vs. adulthood-onset) or excluded sec-
ondary SW related to comorbidities. The current study 
aimed to describe demographic data, clinical and poly-
somnographic features, trigger factors and associated co-
morbidities of AO-SW and CO-SW adult sleepwalkers.
Patients and Methods
Data obtained as part of the clinical routine from 78 subjects 
who were referred, over a period of 12 years, to the sleep centres of 
the University Hospital Bern and the University Hospital Zürich 
and reported SW was retrospectively analyzed. The adult subjects 
were classified as CO-SW if the first episode of SW occurred dur-
ing childhood (<18 years) and as AO-SW if it occurred during 
adulthood.
Fifteen subjects were excluded from analysis due to the high 
amount of missing data (including demographic, clinical data and 
objective assessments) and therefore, 63 subjects were included in 
the analysis. A standard video-polysomnography (v-PSG) has 
been performed in 52 of them as previously described [11]. The v-
PSG consisted of 6 channel electroencephalography (EEG; F3/A2, 
F4/A1, C3/A2, C4/A1, O1/A2, O2/A1), left and right electroocu-
lography, submental, left and right anterior tibialis, flexor carpi 
radialis and adductor digiti minimi electromyography, electrocar-
diography, respiratory flow and effort, and pulse-oximetry. Sleep 
stages and sleep-associated events were manually scored according 
to the American Academy of Sleep Medicine scoring manual [12]. 
In 43 subjects, a 10/20 routine EEG was also performed.
The clinical and epidemiological sleep-wake profile of the pa-
tients was assessed by a structured clinical interview based on the 
“Bern Sleep Questionnaire”. This questionnaire contains ques-
tions regarding demographics, reasons for referral to sleep labora-
tory, general information about sleep-wake habits and sleep prob-
lems, breathing and circulation, parasomnias and potential trigger 
factors, dreaming, dream enactment behaviour, waking-up, day-
time tiredness and sleepiness, cataplexy, hallucinations, stress, 
well-being, neurological, psychiatric and other comorbidities, 
family history and questions regarding pregnancy in female par-
ticipants. In addition, patient’s medical records were reviewed to 
obtain additional information regarding reasons for referral to 
sleep laboratory, neurological and psychiatric comorbidities and 
medication. The time that would be needed to complete the entire 
questionnaire was around 90 min.
Epworth sleepiness scale (ESS) [13] was also performed and 
excessive daytime sleepiness was defined as an ESS score ≥10 [14].
The study was approved by the institutional review board of the 
departments and patients had given their written informed con-
sent for using their data for scientific purposes.
Statistics
Univariate and bivariate analyses: depending on categorical or 
continuous variable and the distribution of the data, chi-square 
test/Fisher’s exact test and unpaired Student t test were performed. 
The SD was used in conjunction with the mean to summarize con-
tinuous data. The level of significance was 0.05 in all tests. All tests 
were calculated using statistical package for social sciences, version 
18 (SPSS-18).
Results
Epidemiological, Clinical and Polysomnographic 
Profile of Sleepwalkers
Data from 63 adult sleepwalkers was collected (age 
39.1 ± 15.3, range 18–80 years, 41 male subjects, 46 sub-
jects with CO-SW, 17 subjects with AO-SW). Excessive 
daytime sleepiness (ESS ≥10) was present in 60% of the 
subjects. Mean ESS was 10.2 ± 5.2. Among the subjects, 
14% reported alcohol consumption on a regular basis. 
Demographic characteristics in our cohort are presented 
in Table 1.
In almost half of the cases, SW was not the reason for be-
ing referred to the sleep centre. The most frequent reasons 
for referral are presented in Table 2. Most sleepwalkers in 
our cohort (45%) had ≥1 episode/month, 22% ≤1 episode/
month, 29% had weekly episodes and only 4% reported very 
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frequent episodes ≥2/week. More than half of the patients 
(54%) had partial recall of the episodes and 36% reported at 
least one trigger factor for SW. The most frequent trigger 
factors were stress (68%), full moon (25%), anxiety (21%), 
alcohol consumption and sleep deprivation (18%).
Almost all sleepwalkers (98%) reported co-occurring 
parasomnias. Sleep talking (91%), night terrors (69%), 
bruxismus (54%) and nocturnal eating behaviour (50%) 
were the most frequently occurring events. In addition, 
hallucinations (45%), sleep paralysis (35%) and enuresis 
(7%) were frequently reported.
Among 52 sleepwalkers who underwent a v-PSG, 27 
subjects (52%) had a sleep latency less than 10 min and 7 
subjects a REM latency less than 60 min, 24 subjects (46%) 
had a sleep efficiency below 85%, 11 subjects (21%) had 
an apnea-hypopnea-index  higher than 10/h, and 11 sub-
jects (21%) had a PLM (periodic limb movements)-index 
higher than 15/h. Sleep architecture was often character-
ized by an increased percentage of stage 1 sleep and de-
creased rapid eye movement (REM) sleep and slow wave 
sleep compared to elsewhere reported age-dependent 
normal values [15]. Table 3 presents the main polysom-
nographic features of subjects with adult SW.
During v-PSG, episodes of SW were observed in 2 sub-
jects (4%) and confusional arousals in 9 subjects (17%). No-
tably, in 3 patients (6%), the criteria for the co-existence of a 
REM-parasomnia (increased phasic muscle activity, jerks 
and increased muscle tone or partial loss of REM atonia 
combined with signs of dream enactment) were fulfilled 
[16].
Childhood- and Adult-Onset Sleepwalking
Among 63 sleepwalkers, 46 subjects reported CO-SW 
and 17 subjects reported AO-SW. Our cohort included 
predominantly males (65%); however, regarding the age 
at onset of SW no male-female differences were found. 
Patients with CO-SW reported more often than those in 
the AO-SW group a positive family history for parasom-
nias (49 vs. 33%; p = 0.04). Neurological comorbidities 
were significantly more often in the AO-SW than in the 
CO-SW (44 vs. 14%; p = 0.02). The most frequent were 
traumatic brain injury, parkinsonism, stroke, alcohol-re-
lated encephalopathy and perinatal cerebral dysfunction. 
In the AO-SW group, there was a trend for more frequent 
occurrences of EEG abnormalities compared to the CO-
SW group; however, the difference was not significant (50 
vs. 29%; p = 0.24). Typical EEG abnormalities included 
slowing activity in basic rhythm and theta activity. No 
epileptic activity was reported.
In our cohort, 29% of the subjects had a psychiatric 
comorbidity, the most frequent one being depression 
(23%). In addition, 14% reported a history of alcohol 
abuse. No differences were observed in the frequency of 
psychiatric comorbidities or alcohol abuse between the 2 
groups (25% in AO-SW vs. 33% in CO-SW; p = 0.39).
Table 1. Demographic characteristics of adult sleepwalkers
Demographics Mean ± SD
Age, years 39.1±15.3
Males 39.8±16.1
Females 38.2±14.4
Males, % 65.1
BMI 26.0±5.3
Males 25.8±5.3
Females 26.2±5.1
ESS 10.2±5.2
Males 10.3±4.0
Females 11.1±7.3
BMI, body mass index; ESS, Epworth Sleepiness Scale.
Table 2. Reasons for referral to the sleep laboratory
Referral Percentage, %
Suspected sleepwalking 60
Suspected sleep apnea 12
Insomnia or hypersomnia 9
Suspected epilepsy 4
Other reasons 15
Table 3. Polysomnographic features of subjects with adult sleep-
walking
PSG variables Mean ± SD
AHI, n/h 8.2±13.1
Mean desaturation, % 4.3±8.9
Sleep latency, min 20.2±44.0
REM latency, min 125.2±79.5
Sleep efficiencya 81.1±17.3
REM sleep, %a 10.1±6.2
NREM1 sleep, %a 22.4±11.8
NREM2 sleep, %a 41.1±12.2
NREM3 sleep, %a 14.3±7.1
PLM-index 8.1±28.8
a Percentage of the total sleep time, n = 52
PSG, polysomnography; AHI, Apnoe-Hypopnea Index; REM, 
rapid eye movement; NREM, non-rapid eye movement; PLM, Pe-
riodic limb movements.
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In our cohort, 40% of the adult sleepwalkers reported 
violent behaviour during SW and 42% reported self-inju-
ries. Among them 72 (62.5%) were males. In the AO-SW 
group, 45% of the patients reported episodes with self-
injury and 44% episodes with violent behaviour. For the 
patients in the CO-SW group, these percentages were 
33% (p = 0.32) and 29% (p = 0.03) for self-injury and vio-
lent behaviour respectively. The differences between CO- 
and AO-SW are presented in Table 4.
Discussion
In the current study, we assessed characteristics of adult 
sleepwalkers and differences between AO- and CO-SW.
The profile of subjects with AO-SW differs from that 
of those with CO-SW. We confirmed previous reports 
that nearly 40% of individuals with SW had a family his-
tory of such a disorder [6]. However, in the subgroup anal-
ysis, not surprisingly, familial occurrence was significant-
ly more frequent in the CO-SW compared to the AO-SW 
group. Neurological comorbidities were present in 23% of 
the subjects and were twice more frequent in the AO-SW 
group compared to subjects with CO-SW. Consequently, 
more subjects in the AO-SW group exhibited EEG abnor-
malities. In our cohort, nearly one-third of the subjects 
reported a psychiatric comorbidity; however, we could 
not confirm previous reports that psychiatric comorbidi-
ties or alcohol abuse are more often in subjects with AO-
SW. We confirmed previous reports that violent episodes 
during SW are more frequently reported by male sleep-
walkers [17] which might, at least partially, explain the 
more frequent referral of male sleepwalkers to our sleep 
centres. Adults with CO-SW reported less self-injuries, 
and the episodes of SW were significantly less violent 
compared to those in adults with AO-SW.
Often the first therapeutic approach of SW is based on 
the treatment of comorbidities or the management of trig-
ger factors. Therefore, we focused on the demographic, 
clinical and polysomnographic profile, trigger factors and 
associated comorbidities of adult sleepwalkers. The de-
mographic characteristics of our cohort did not differ sig-
nificantly from those reported from previous studies. 
Sleep walking was more frequently reported in the cate-
gory ≥1 episode/month and less frequent in the category 
≥2 episodes/week. Consistent with previous reports [7], 
one-third of the subjects reported at least one SW trigger 
factor. Stress was mentioned by almost two-thirds of them 
and sleep deprivation, anxiety and alcohol consumption 
were also frequently reported. Interestingly, full moon 
was reported by 25% of our patients as a trigger factor, 
suggesting a periodic occurrence of the episodes, whereas 
in previous studies, it was rarely mentioned [9] or not 
mentioned at all. In our cohort, as in previous studies [18, 
19], there were more males among sleepwalkers. This 
does not necessarily reflect an association of SW with gen-
der [6] but possibly differences in the referral rates, which 
are likely due to the fact that male sleepwalkers have more 
frequent violent episodes than female sleepwalkers.
During night polysomnography, sleep efficiency and 
frequency of confusional arousals or episodes of SW in 
our cohort were comparable to previous studies [9]. 
However, sleepiness was almost 4-times and sleep disor-
dered breathing (SDB) almost twice more frequent than 
previously reported [9]. It still remains unclear if and why 
subjects with SDB become more susceptible to SW. Based 
on the hypothesis that sleep disruption due to SDB could 
increase arousability, which under specific conditions 
(e.g., trigger factors) could lead to SW [19], early studies 
suggested that obstructive sleep apnea syndrome is asso-
ciated with SW and treatment of the SDB could reduce 
susceptibility to SW [19–21].
Comorbid parasomnias are very frequent among 
sleepwalkers. The frequency of comorbid sleep talking 
and night terrors in our cohort was similar to previous 
reports [7]. To our knowledge, this study is the first to 
report the prevalence of bruxism, nocturnal hallucina-
tions, sleep paralysis and enuresis in a cohort of sleep-
walkers. Interestingly, 6% of the patients also fulfilled the 
polysomnographic and clinical criteria of a REM para-
somnia, suggesting the existence of an overlap parasom-
nia. The prevalence of REM sleep behaviour disorder 
(RBD) is about 0.5% in the general population and 2% in 
Table 4. Differences between AO- and CO-SW
CO-SW, % AO-SW, % p value
Males 61 71 0.34
Positive family history for
parasomnias 49 33 0.04
Neurological comorbidities 14 44 0.02
Psychiatric comorbidities 33 25 0.39
Abnormalities in EEG 29 50 0.24
Sleepwalking-related
self-injuries 45 33 0.32
Violent behavior during
sleepwalking 44 29 0.03
AO-SW, adult-onset sleepwalkers; CO-SW, childhood-onset 
sleepwalkers; EEG, electroencephalography.
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the older adult population [22]. Our data supports previ-
ous reports of an increased prevalence of SW among pa-
tients with RBD [11, 23]. RBD is considered a preclinical 
marker for neurodegenerative disorders and therefore 
the prevalence of overlap parasomnia among sleepwalk-
ers needs further investigation.
The comparison of unequal sample sizes is a limitation 
of the current study. However, considering the low per-
centage of AO-SW among adult sleepwalkers (e.g., 13% 
in Lopez et al. [7], 20% in Labelle et al. [8]), the formation 
of equal sample sizes would require a prospective ap-
proach.
Our data indicates that adult SW represents a complex 
and potentially dangerous condition and underpin the 
importance of a detailed history taking, clinical, and poly-
somnographic assessment of adult sleepwalkers. Psychi-
atric and neurological comorbidities (for the latest espe-
cially in subjects with AO-SW) but also comorbid sleep-
related disorders (e.g., SDB, overlap parasomnia) should 
be assessed and if indicated should be treated. This, to-
gether with a comprehensive counseling regarding prog-
nosis (e.g., increased risk of experiencing violent or even 
self-injurious behaviour especially for subjects with CO-
SW) consists an essential initial step towards the success-
ful management of SW.
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